Information Technology - News & Updates

Bayer has entered into a strategic drug discovery collaboration with Iambic Therapeutics to accelerate the development of new small-molecule medicines using artificial intelligence. The…
Read More...

XtalPi has entered into a strategic collaboration with a leading international biopharmaceutical company to develop a next-generation small-molecule therapy targeting a complex G…
Read More...

Alnylam Pharmaceuticals and Inceptive Nucleics have entered into a strategic collaboration valued at up to $2 billion aimed at accelerating the development of next-generation RNA-based…
Read More...

Insilico Medicine and Human Life Foundation Models, Inc. (HLFM) have entered into a multi-million-dollar collaboration to develop what the companies describe as the biotechnology…
Read More...

Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery for biotechnology companies through a success-based artificial…
Read More...

QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...

Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence agents designed to support biopharmaceutical decision-making and…
Read More...

MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with Google Cloud aimed at transforming the pharmaceutical giant into a fully…
Read More...

Boehringer Ingelheim has announced a major expansion of its global Computational Innovation network with the launch of a new artificial intelligence (AI) and machine learning (ML)…
Read More...

Viz.ai has announced a strategic partnership with Alnylam Pharmaceuticals aimed at improving the early detection and diagnosis of cardiac amyloidosis, a serious and often underdiagnosed…
Read More...

Roche has announced a major expansion of its global artificial intelligence (AI) infrastructure, unveiling a large-scale “AI factory” powered by next-generation accelerated computing…
Read More...

Merck & Co., Inc., known as MSD outside the United States and Canada, has entered into a major research and development agreement with Mayo Clinic to apply artificial intelligence…
Read More...

Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical System Holdings have announced a multi-project collaboration aimed at…
Read More...

Takeda has entered a multi-year collaboration with clinical-stage biotechnology company Iambic aimed at accelerating the development of new medicines using artificial…
Read More...

Bristol Myers Squibb (BMS) has entered into a strategic collaboration with Microsoft to accelerate the early detection of lung cancer by integrating advanced artificial intelligence…
Read More...

AstraZeneca has acquired Modella AI, a life sciences–focused artificial intelligence company, in a move that deepens the companies’ existing collaboration and strengthens AstraZeneca’s…
Read More...

The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have jointly agreed on ten principles for good artificial intelligence (AI) practice across the…
Read More...

Illumina has unveiled what it calls the world’s largest genome-wide genetic perturbation dataset, a major initiative designed to accelerate artificial intelligence–driven drug discovery…
Read More...

Insilico Medicine, a clinical-stage company pioneering generative AI-driven drug discovery, has announced a new research collaboration with Eli Lilly and Company to jointly develop…
Read More...

Harbour BioMed and Evinova have announced a strategic collaboration to integrate artificial intelligence (AI) and digital technologies into biologics research and development. The…
Read More...